Article
[Importance of genotyping of thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy].
Srpski arhiv za celokupno lekarstvo - 1 Jan 2000
Dokmanović Lidija, Janić Dragana, Krstovski Nada, Zukić Branka, Tosić Natasa, Pavlović Sonja
Abstract excerpt
INTRODUCTION: Thiopurine S-methyltransferase (TPMT) is an enzyme that catalyses the inactivation of mercaptopurine (MP) which is widely used in the treatment of acute lymphoblastic leukaemia (ALL) of childhood. Potentially fatal myelotoxicity may develop after standard doses of MP in TPMT deficient patients. OBJECTIVES: To establish if individually tailored doses of MP can reduce myelotoxicity in ALL patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
